Homepage   About us   Products   Services   Clinical Trials   Partners   Investor Relations   News & Events   Contact us     Respiratory Intravenous AAT (Alpha-1 Antitrypsin) Aerosolized AAT ** (Alpha-1 Antitrypsin) Aerosolized AAT ** (Alpha-1 Antitrypsin) Aerosolized AAT ** (Alpha-1 Antitrypsin)   Immunoglobulins KamRAB (Human rabies immunoglobulin/HRIG) KamRho-D IM (Human Anti-D (Rho) immunoglobulin KamRho-D IV (Human Anti-D (Rho) immunoglobulin) IVIG* (IgG immunoglobulins)   Critical care Protosol (Aprotinin) Heparin sodium injection Heparin Lock Flush Kamacaine 0.5% Albumin*   Coagulation Factors Factor IX* Factor VIII, VWF*   Additional Specialty Proteins Human Transferrin **     Products Kamada develops, produces and markets high-quality bio-therapeutics for human use, including specialty proteins, specific immunoglobulins and other prescription medicines. These products are manufactured using unique proprietary technologies. Several of Kamada's products are marketed in Israel and in 15 other countries worldwide. Profiles for a selection of these products are provided for your information The company product line and development pipeline includes: Category Product Indication Respiratory   Intravenous AAT (Alpha-1 Antitrypsin)   Alpha-1 Antitrypsin Deficiency       Aerosolized AAT ** (Alpha-1 Antitrypsin)   Alpha-1 Antitrypsin Deficiency (AATD)       Aerosolized AAT ** (Alpha-1 Antitrypsin)   Cystic Fibrosis(CF)       Aerosolized AAT ** (Alpha-1 Antitrypsin)   Bronchiectasis   Immunoglobulins   KamRAB (Human rabies immunoglobulin/HRIG)   Prophylaxis of Rabies infection       KamRho-D IM (Human Anti-D (Rho) immunoglobulin   Prophylaxis of hemolytic disease of the newborn       KamRho-D IV (Human Anti-D (Rho) immunoglobulin)   Immune Thrombocytopenic Purpura (ITP)       IVIG* (IgG immunoglobulins)   Primary and secondary Immune deficiencies   Critical care   Protosol (Aprotinin)   Reduction of blood loss during cardiac surgery       Heparin sodium injection   Coagulation inhibition, prophylaxis of thromboembolic diseases       Heparin Lock Flush   Maintenance of potency of intravenous injection device       Kamacaine 0.5%   Local, epidural or spinal anesthesia       Albumin*   Therapeutic plasma exchange, hypovolemic shock   Coagulation Factors   Factor IX*   Hemophilia B: Treatment of bleeding episodes and maintenance of plasma factor IX levels       Factor VIII, VWF*   Hemophilia A: Treatment of bleeding episodes and maintenance of plasma factor VIII levels, vonwillebrand disease   Additional Specialty Proteins   Human Transferrin **   For in vitro and diagnostic use For pharmaceutical use   * Imported products marketed worldwide ** Under development     All rights reserved to Kamada © 2008 Terms and Conditions | Privacy Policy | Colours